These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26729489)

  • 1. Sterol O-Acyltransferase 2-Driven Cholesterol Esterification Opposes Liver X Receptor-Stimulated Fecal Neutral Sterol Loss.
    Warrier M; Zhang J; Bura K; Kelley K; Wilson MD; Rudel LL; Brown JM
    Lipids; 2016 Feb; 51(2):151-7. PubMed ID: 26729489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted depletion of hepatic ACAT2-driven cholesterol esterification reveals a non-biliary route for fecal neutral sterol loss.
    Brown JM; Bell TA; Alger HM; Sawyer JK; Smith TL; Kelley K; Shah R; Wilson MD; Davis MA; Lee RG; Graham MJ; Crooke RM; Rudel LL
    J Biol Chem; 2008 Apr; 283(16):10522-34. PubMed ID: 18281279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute sterol o-acyltransferase 2 (SOAT2) knockdown rapidly mobilizes hepatic cholesterol for fecal excretion.
    Marshall SM; Gromovsky AD; Kelley KL; Davis MA; Wilson MD; Lee RG; Crooke RM; Graham MJ; Rudel LL; Brown JM; Temel RE
    PLoS One; 2014; 9(6):e98953. PubMed ID: 24901470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of sterol O-acyltransferase 2 (SOAT2) function in mice deficient in lysosomal acid lipase (LAL) dramatically reduces esterified cholesterol sequestration in the small intestine and liver.
    Lopez AM; Posey KS; Turley SD
    Biochem Biophys Res Commun; 2014 Nov; 454(1):162-6. PubMed ID: 25450374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Knockdown of Hepatic SOAT2 With Antisense Oligonucleotides Stabilizes Atherosclerotic Plaque in ApoB100-only LDLr-/- Mice.
    Melchior JT; Olson JD; Kelley KL; Wilson MD; Sawyer JK; Link KM; Rudel LL
    Arterioscler Thromb Vasc Biol; 2015 Sep; 35(9):1920-7. PubMed ID: 26229140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol esters (CE) derived from hepatic sterol O-acyltransferase 2 (SOAT2) are associated with more atherosclerosis than CE from intestinal SOAT2.
    Zhang J; Sawyer JK; Marshall SM; Kelley KL; Davis MA; Wilson MD; Brown JM; Rudel LL
    Circ Res; 2014 Oct; 115(10):826-33. PubMed ID: 25239141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New pyripyropene A derivatives, highly SOAT2-selective inhibitors, improve hypercholesterolemia and atherosclerosis in atherogenic mouse models.
    Ohshiro T; Ohtawa M; Nagamitsu T; Matsuda D; Yagyu H; Davis MA; Rudel LL; Ishibashi S; Tomoda H
    J Pharmacol Exp Ther; 2015 Nov; 355(2):299-307. PubMed ID: 26338984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Niemann-Pick C1-deficient mice lacking sterol O-acyltransferase 2 have less hepatic cholesterol entrapment and improved liver function.
    Lopez AM; Jones RD; Repa JJ; Turley SD
    Am J Physiol Gastrointest Liver Physiol; 2018 Oct; 315(4):G454-G463. PubMed ID: 29878847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of loss of SOAT2 function on disease progression in the lysosomal acid lipase-deficient mouse.
    Lopez AM; Chuang JC; Turley SD
    Steroids; 2018 Feb; 130():7-14. PubMed ID: 29246491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic depletion of Soat2 diminishes hepatic steatosis via genes regulating de novo lipogenesis and by GLUT2 protein in female mice.
    Ahmed O; Pramfalk C; Pedrelli M; Olin M; Steffensen KR; Eriksson M; Parini P
    Dig Liver Dis; 2019 Jul; 51(7):1016-1022. PubMed ID: 30630736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delineation of metabolic responses of Npc1
    Ramirez CM; Taylor AM; Lopez AM; Repa JJ; Turley SD
    Steroids; 2020 Dec; 164():108725. PubMed ID: 32890578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conjugated and non-conjugated octadecaenoic acids affect differently intestinal acyl coenzyme A: cholesterol acyltransferase activity.
    Lam CK; Chen J; Cao Y; Yang L; Wong YM; Yeung SY; Yao X; Huang Y; Chen ZY
    Atherosclerosis; 2008 May; 198(1):85-93. PubMed ID: 18078940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol-lowering activity of sesamin is associated with down-regulation on genes of sterol transporters involved in cholesterol absorption.
    Liang YT; Chen J; Jiao R; Peng C; Zuo Y; Lei L; Liu Y; Wang X; Ma KY; Huang Y; Chen ZY
    J Agric Food Chem; 2015 Mar; 63(11):2963-9. PubMed ID: 25745846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can non-cholesterol sterols and lipoprotein subclasses distribution predict different patterns of cholesterol metabolism and statin therapy response?
    Gojkovic T; Vladimirov S; Spasojevic-Kalimanovska V; Zeljkovic A; Vekic J; Kalimanovska-Ostric D; Djuricic I; Sobajic S; Jelic-Ivanovic Z
    Clin Chem Lab Med; 2017 Mar; 55(3):447-457. PubMed ID: 27718480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stigmasterol stimulates transintestinal cholesterol excretion independent of liver X receptor activation in the small intestine.
    Lifsey HC; Kaur R; Thompson BH; Bennett L; Temel RE; Graf GA
    J Nutr Biochem; 2020 Feb; 76():108263. PubMed ID: 31759199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRD125, a potent and selective inhibitor of sterol O-acyltransferase 2 markedly reduces hepatic cholesteryl ester accumulation and improves liver function in lysosomal acid lipase-deficient mice.
    Lopez AM; Chuang JC; Posey KS; Ohshiro T; Tomoda H; Rudel LL; Turley SD
    J Pharmacol Exp Ther; 2015 Nov; 355(2):159-67. PubMed ID: 26283692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis.
    Hsieh J; Koseki M; Molusky MM; Yakushiji E; Ichi I; Westerterp M; Iqbal J; Chan RB; Abramowicz S; Tascau L; Takiguchi S; Yamashita S; Welch CL; Di Paolo G; Hussain MM; Lefkowitch JH; Rader DJ; Tall AR
    Nature; 2016 Jul; 535(7611):303-7. PubMed ID: 27383786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The low density lipoprotein receptor pathway in animals and man.
    Shepherd J; Packard CJ
    Health Bull (Edinb); 1982 Jul; 40(4):197-205. PubMed ID: 6288622
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of HMG-CoA reductase inhibition on hepatic expression of key cholesterol-regulatory enzymes and receptors in nephrotic syndrome.
    Vaziri ND; Liang K
    Am J Nephrol; 2004; 24(6):606-13. PubMed ID: 15583480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of lecithin-cholesterol acyltransferase activity measured as a serum cholesterol esterification rate and low-density lipoprotein heterogeneity with cardiovascular risk: a cross-sectional study.
    Tani S; Takahashi A; Nagao K; Hirayama A
    Heart Vessels; 2016 Jun; 31(6):831-40. PubMed ID: 25894629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.